ArticleJournal of family medicine and primary care2025
Development, validation and feasibility testing of a 12-minute Yoga-Breath Linked Intervention to Stop Smoking (Y-BLISS) module.
Article in Journal of family medicine and primary care, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objectives: This study aimed to develop and validate the yoga-breath-linked intervention to stop smoking (Y-BLISS), a novel, scalable, and cost-effective yoga-based module for smoking cessation as an add-on to standard care. Methods: Thirty experts from yoga, psychiatry, and clinical psychology backgrounds evaluated a selection of yoga practices and brief yoga philosophy-based psychotherapeutic (BYPP) concepts for their potential efficacy in smoking cessation using the Content Validity Ratio (CVR), with a cut-off of 0.4. The final intervention module included ten items (8 practices and 2 psychotherapeutic concepts). The module was tested over two months with 26 participants (25 males) diagnosed with tobacco use disorder as per DSM -5 and enrolled in a smoking cessation program, with Fagerström Nicotine Dependence Scale (FTND) scores of 6 or above. Participants attended 15-25 sessions (including a single BYPP session) and provided feedback on safety, feasibility, and clinical outcomes. Results: Sixteen subjects provided post-data at 8 weeks. The module received high safety ratings (9-10) with no adverse effects. The analysis revealed a significant reduction in FTND scores from baseline to weeks 4 and 8, F (2,14) = 13.93; Conclusion: Y-BLISS module including single session of BYPP was found to be a feasible and safe adjunctive tool for smoking cessation programs. These findings support further evaluation in randomized controlled trials to assess its efficacy and potential as part of integrative approaches toward management of tobacco use disorder. This could impact public health primary care if scaled up with high coverage.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.